News/ News/ Oncology BI investigates cancer ‘dark antigens’ with UK’s Enara Richard Staines Boehringer Ingelheim, cancer, Enara Bio, Oncology 0 Comment Boehringer Ingelheim has signed a strategic collaboration with UK biotech Enara Bio, focused on finding ways to fight Share X BI investigates cancer ‘dark antigens’ with UK’s Enara https://pharmaphorum.com/news/boehringer-to-investigate-dark-antigens-with-uk-cancer-specialist-enara/
